EMRICASAN NCT02686762


Laboratory : CONATUS

Study Name : 

Phase 2

Study Number : NCT02686762

Number of patients recruited : 330

Probability to be under placebo : 33%

Contacts : 

Contact: Lisa Grubbs (858) 376-2627

lgrubbs@conatuspharma.com


Contact: Beth Sheedy (858) 376-2600

bsheedy@conatuspharma.com











Share on StockTwits

WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE